|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eisenberg D, Marcotte EM, Xenarios I and
Yeates TO: Protein function in the post-genomic era. Nature.
405:823–826. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steck E, Breit S, Breusch SJ, Axt M and
Richter W: Enhanced expression of the human chitinase 3-like 2 gene
(YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic
cartilage. Biochem Biophys Res Commun. 299:109–115. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yue CM, Deng DJ, Bi MX, Guo LP and Lu SH:
Expression of ECRG4, a novel esophageal cancer-related gene,
downregulated by CpG island hypermethylation in human esophageal
squamous cell carcinoma. World J Gastroenterol. 9:1174–1178. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kao S, Shaterian A, Cauvi DM, Dang X, Chun
HB, De Maio A, Costantini TW, Coimbra R, Eliceiri BP and Baird A:
Pulmonary preconditioning, injury and inflammation modulate
expression of the candidate tumor suppressor gene ECRG4 in lung.
Exp Lung Res. 41:162–172. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Podvin S, Dang X, Meads M, Kurabi A,
Costantini T, Eliceiri BP, Baird A and Coimbra R: Esophageal
cancer-related gene-4 (ECRG4) interactions with the innate immunity
receptor complex. Inflamm Res. 64:107–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huh YH, Ryu JH, Shin S, Lee DU, Yang S, Oh
KS, Chun CH, Choi JK, Song WK and Chun JS: Esophageal cancer
related gene 4 (Ecrg4) is a marker of articular chondrocyte
differentiation and cartilage destruction. Gene. 448:7–15. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kujuro Y, Suzuki N and Kondo T: Esophageal
cancer-related gene 4 is a secreted inducer of cell senescence
expressed by aged CNS precursor cells. Proc Natl Acad Sci USA.
107:8259–8264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsuzaki J, Torigoe T, Hirohashi Y,
Kamiguchi K, Tamura Y, Tsukahara T, Kubo T, Takahashi A, Nakazawa
E, Saka E, et al: ECRG4 is a negative regulator of
caspase-8-mediated apopotosis in human T-leukemia cells.
Carcinogenesis. 33:996–1003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shaterian A, Kao S, Chen L, DiPietro LA,
Coimbra R, Eliceiri BP and Baird A: The candidate tumor suppressor
gene Ecrg4 as a wound terminating factor in cutaneous injury. Arch
Dermatol Res. 305:141–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Podvin S, Gonzalez AM, Miller MC, Dang X,
Botfield H, Donahue JE, Kurabi A, BoissaudCooke M, Rossi R,
Leadbeater WE, et al: Esophageal cancer related gene-4 is a choroid
plexus-derived injury response gene: Evidence for a biphasic
response in early and late brain injury. PLoS One. 6:e246092011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gonzalez AM, Podvin S, Lin SY, Miller MC,
Botfield H, Leadbeater WE, Roberton A, Dang X, Knowling SE,
CardenasGalindo E, et al: Ecrg4 expression and its product augurin
in the choroid plexus: Impact on fetal brain development,
cerebrospinal fluid homeostasis and neuroprogenitor cell response
to CNS injury. Fluids Barriers CNS. 8:62011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kurabi A, Pak K, Dang X, Coimbra R,
Eliceiri BP, Ryan AF and Baird A: Ecrg4 attenuates the inflammatory
proliferative response of mucosal epithelial cells to infection.
PLoS One. 8:e613942013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Götze S, Feldhaus V, Traska T, Wolter M,
Reifenberger G, Tannapfel A, Kuhnen C, Martin D, Müller O and
Sievers S: ECRG4 is a candidate tumor suppressor gene frequently
hypermethylated in colorectal carcinoma and glioma. BMC Cancer.
9:4472009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu J, Wen M, Huang Y, He X, Wang Y, Wu Q,
Li Z, CastellanosMartin A, Abad M, CruzHernandez JJ, et al: C2ORF40
suppresses breast cancer cell proliferation and invasion through
modulating expression of M phase cell cycle genes. Epigenetics.
8:571–583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mori Y, Ishiguro H, Kuwabara Y, Kimura M,
Mitsui A, Kurehara H, Mori R, Tomoda K, Ogawa R, Katada T, et al:
Expression of ECRG4 is an independent prognostic factor for poor
survival in patients with esophageal squamous cell carcinoma. Oncol
Rep. 18:981–985. 2007.PubMed/NCBI
|
|
17
|
Li W, Liu X, Zhang B, Qi D, Zhang L, Jin Y
and Yang H: Overexpression of candidate tumor suppressor ECRG4
inhibits glioma proliferation and invasion. J Exp Clin Cancer Res.
29:892010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsuzaki J, Torigoe T, Hirohashi Y,
Tamura Y, Asanuma H, Nakazawa E, Saka E, Yasuda K, Takahashi S and
Sato N: Expression of ECRG4 is associated with lower proliferative
potential of esophageal cancer cells. Pathol Int. 63:391–397. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu T, Xiao D and Zhang X: ECRG4 inhibits
growth and invasiveness of squamous cell carcinoma of the head and
neck in vitro and in vivo. Oncol Lett. 5:1921–1926. 2013.PubMed/NCBI
|
|
20
|
Wang YB and Ba CF: Promoter methylation of
esophageal cancer-related gene 4 in gastric cancer tissue and its
clinical significance. Hepatogastroenterology. 59:1696–1698.
2012.PubMed/NCBI
|
|
21
|
Sabatier R, Finetti P, Adelaide J, Guille
A, Borg JP, Chaffanet M, Lane L, Birnbaum D and Bertucci F:
Down-regulation of ECRG4, a candidate tumor suppressor gene, in
human breast cancer. PLoS One. 6:e276562011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baird A, Lee J, Podvin S, Kurabi A, Dang
X, Coimbra R, Costantini T, Bansal V and Eliceiri BP: Esophageal
cancer-related gene 4 at the interface of injury, inflammation,
infection, and malignancy. Gastrointest Cancer. 2014:131–142. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
You Y, Yang W, Qin X, Wang F, Li H, Lin C,
Li W, Gu C, Zhang Y and Ran Y: ECRG4 acts as a tumor suppressor and
as a determinant of chemotherapy resistance in human nasopharyngeal
carcinoma. Cell Oncol (Dordr). 38:205–214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang CP, Wu BH, Wang BQ, Fu MY, Yang M,
Zhou Y and Liu F: Overexpression of ECRG4 enhances chemosensitivity
to 5-fluorouracil in the human gastric cancer SGC-7901 cell line.
Tumour Biol. 34:2269–2273. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li LW, Yu XY, Yang Y, Zhang CP, Guo LP and
Lu SH: Expression of esophageal cancer related gene 4 (ECRG4), a
novel tumor suppressor gene, in esophageal cancer and its
inhibitory effect on the tumor growth in vitro and in vivo. Int J
Cancer. 125:1505–1513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li L, Zhang C, Li X, Lu S and Zhou Y: The
candidate tumor suppressor gene ECRG4 inhibits cancer cells
migration and invasion in esophageal carcinoma. J Exp Clin Cancer
Res. 29:1332010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li LW, Li YY, Li XY, Zhang CP, Zhou Y and
Lu SH: A novel tumor suppressor gene ECRG4 interacts directly with
TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal
carcinoma. BMC Cancer. 11:522011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li LW, Yang Y, Li XY, Guo LP, Zhou Y and
Lu SX: Tumor-suppressing function of human esophageal cancer
related gene 4 in esophageal squamous cell carcinoma. Zhonghua Yi
Xue Za Zhi. 90:2713–2717. 2010.(In Chinese). PubMed/NCBI
|
|
29
|
Li LW, Yu XY, Li XY, Guo LP, Zhou Y and Lu
SX: Mechanism of loss of human esophageal cancer-related gene 4
(ECRG4) gene expression in esophageal squamous cell carcinoma cell
line EC9706. Zhonghua Zhong Liu Za Zhi. 33:570–573. 2011.(In
Chinese). PubMed/NCBI
|
|
30
|
Li X, Li L, Wang W, Yang Y, Zhou Y and Lu
S: Soluble purified recombinant C2ORF40 protein inhibits esophageal
cancer cells proliferation by inducing cell cycle G1 phase block.
Oncol Lett. 10:1593–1596. 2015.PubMed/NCBI
|
|
31
|
Wang W, Fan H, Li X, Wu G, Zhao W, Zhang
G, Zhao G and Li LW: Beclin 1 promotes apoptosis and decreases
invasion by upregulating the expression of ECRG4 in A549 human lung
adenocarcinoma cells. Mol Med Rep. 14:355–360. 2016.PubMed/NCBI
|
|
32
|
Fleisig HB and Wong JMY: Telomerase
promotes efficient cell cycle kinetics and confers growth advantage
to telomerase-negative transformed human cells. Oncogene.
31:954–965. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rana C, Piplani H, Vaish V, Nehru B and
Sanyal SN: Downregulation of telomerase activity by diclofenac and
curcumin is associated with cell cycle arrest and induction of
apoptosis in colon cancer. Tumour Biol. 36:5999–6010. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu L, Li S and Stohr BA: The role of
telomere biology in cancer. Annu Rev Pathol. 8:49–78. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Baird A, Coimbra R, Dang X, Lopez N, Lee
J, Krzyzaniak M, Winfield R, Potenza B and Eliceiri BP: Cell
surface localization and release of the candidate tumor suppressor
ECRG4 from polymorphonuclear cells and monocytes activate
macrophages. J Leukoc Biol. 91:773–781. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dang X, Podvin S, Coimbra R, Eliceiri B
and Baird A: Cell-specific processing and release of the
hormone-like precursor and candidate tumor suppressor gene product,
ECRG4. Cell Tissue Res. 348:505–514. 2012. View Article : Google Scholar : PubMed/NCBI
|
